Skip to content
Search

Latest Stories

MHRA issues recall notice for Oxylan 40mg tablets  

pharmacy.biz Staff
By pharmacy.biz StaffSep 03, 2020
pharmacy.biz Staff
See Full Bio

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Oxylan 40mg prolonged-release tablets of GL Pharma.

GL Pharma is recalling the below batch of the tablets due to out of specification results for dissolution obtained during routine stability testing.

Product Details

Oxylan 40mg prolonged-release tablets, PL 21597/0064

Active pharmaceutical ingredient: Oxycodone Hydrochloride

Batch NumberExpiry DatePack SizeFirst Distributed
9F119A31/05/20245602/06/2020

The healthcare professionals have been adviced to stop supplying the batch immediately and remove it from the shelves within the pharmacy.

It has also been suggested to quarantine all remaining stock and return it to the supplier using approved process.

Related News

13 pharmacists achieve RPS core advanced credential with record pass rate
News

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

Man jailed for running illegal online pharmacy, selling prescription medication
News

Man who posed as online pharmacist 'Dr T' jailed for over 10 years

Government launches call for evidence on England’s first ever men’s health strategy
News

Call for Evidence: Streeting urges public to help shape men’s health strategy

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS
News

RPS urges GPhC to reduce registration fees for non-practising pharmacists

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc